Sign In
Last checked at 
30 Jan 2009 07:00
ο»Ώ
Amphion Innovations plc
Funding Update
London and New York,Β 30Β JanuaryΒ 2009Β - Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announcesΒ that it hasΒ receivedΒ a further subscription ofΒ Β£408,750Β for theΒ ConvertibleΒ Promissory Note, first announced on 31 December 2008. This brings the total amount issued toΒ Β£2,599,650Β on the same termsΒ as previously announced.Β
For furtherΒ information please contact
Amphion Innovations Charlie Morgan +1 212 210 6224
Cardew GroupTim Robertson/ Jamie Milton/ Matthew Law +44 20 7930 0777
Charles StanleyΒ (Nominated Adviser) Mark Taylor/ Freddy Crossley +44 20 7149 6000
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 8Β Partner Companies, developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.
On the web:Β www.amphionplc.comΒ
Follow the stocks
